Clinical Trials Directory

Trials / Completed

CompletedNCT02243943

Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile

Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Leiden University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Suboptimal reversal of neuromuscular blockage after surgery is possibly related to unfavorable postoperative respiratory conditions and elevated pain levels. Rapid and complete reversal of neuromuscular block was not possible untill sugammadex was discovered. The investigators hyposthesise that reversal with sugammadex leads to favorable postoperative respiratory conditions and less pain compared to reversal with neostigmine.

Conditions

Interventions

TypeNameDescription
DRUGSugammadex
DRUGNeostigmine

Timeline

Start date
2014-09-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2014-09-18
Last updated
2017-02-06
Results posted
2016-08-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02243943. Inclusion in this directory is not an endorsement.

Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile (NCT02243943) · Clinical Trials Directory